Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.
Tsutani Y, Miyata Y, Masuda T, Fujitaka K, Doi M, Awaya Y, Kuyama S, Kitaguchi S, Ueda K, Hattori N, Okada M. Tsutani Y, et al. Among authors: awaya y. BMC Cancer. 2018 Dec 10;18(1):1231. doi: 10.1186/s12885-018-5146-3. BMC Cancer. 2018. PMID: 30526545 Free PMC article. Clinical Trial.
Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II study.
Hamai K, Fujitaka K, Kitaguchi S, Tamamoto S, Takao S, Nishida A, Furutama J, Horimasu Y, Masuda T, Miyamoto S, Awaya Y, Kondo T, Shoda H, Ishikawa N, Yamasaki M, Hattori N. Hamai K, et al. Among authors: awaya y. Anticancer Drugs. 2021 Aug 1;32(7):767-772. doi: 10.1097/CAD.0000000000001079. Anticancer Drugs. 2021. PMID: 33967202 Clinical Trial.
Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer.
Masuda T, Fujitaka K, Ishikawa N, Nakano K, Yamasaki M, Kitaguchi S, Masuda K, Yamaguchi K, Sakamoto S, Horimasu Y, Kawase S, Miyamoto S, Nakashima T, Iwamoto H, Shiota N, Senoo T, Awaya Y, Kondo T, Yoshida T, Hamada H, Murakami I, Hattori N. Masuda T, et al. Among authors: awaya y. J Thorac Dis. 2020 Mar;12(3):1079-1084. doi: 10.21037/jtd.2019.12.46. J Thorac Dis. 2020. PMID: 32274176 Free PMC article.
Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis.
Ohashi K, Ninomiya K, Yoshioka H, Bessho A, Shibayama T, Aoe K, Ishikawa N, Kozuki T, Kawai H, Kuyama S, Miyoshi S, Fujitaka K, Obata H, Tsubata Y, Awaya Y, Inoue M, Inoue K, Horita N, Yanai H, Hotta K, Kiura K. Ohashi K, et al. Among authors: awaya y. Lung Cancer. 2020 Dec;150:83-89. doi: 10.1016/j.lungcan.2020.09.024. Epub 2020 Oct 1. Lung Cancer. 2020. PMID: 33096420
Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol.
Nishii K, Inoue M, Obata H, Ueda Y, Kozuki T, Yamasaki M, Moritaka T, Awaya Y, Sugimoto K, Gemba K, Kuyama S, Ichikawa H, Shibayama T, Kubota T, Kodani M, Kishino D, Fujimoto N, Ishikawa N, Tsubata Y, Ishii T, Fujitaka K, Hotta K, Kiura K. Nishii K, et al. Among authors: awaya y. Thorac Cancer. 2021 Mar;12(5):725-731. doi: 10.1111/1759-7714.13789. Epub 2021 Jan 12. Thorac Cancer. 2021. PMID: 33434415 Free PMC article.
Alteration in length of telomeric repeats in lung cancer.
Shirotani Y, Hiyama K, Ishioka S, Inyaku K, Awaya Y, Yonehara S, Yoshida Y, Inai K, Hiyama E, Hasegawa K, et al. Shirotani Y, et al. Among authors: awaya y. Lung Cancer. 1994 Jul;11(1-2):29-41. doi: 10.1016/0169-5002(94)90280-1. Lung Cancer. 1994. PMID: 8081703
Hochuekkito Combined with Pulmonary Rehabilitation in Apathetic Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Pilot Trial.
Hamada H, Sekikawa K, Okusaki K, Dodo T, Kagawa K, Sumigawa T, Awaya Y, Sakimoto N, Shioya S, Hakozaki K, Kadowaki T, Kakimoto M, Ito R, Kawamichi K, Kondo K, Namba H, Iwamoto H, Hattori N. Hamada H, et al. Among authors: awaya y. J Clin Med. 2022 Sep 26;11(19):5673. doi: 10.3390/jcm11195673. J Clin Med. 2022. PMID: 36233538 Free PMC article.
115 results